Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins

Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV18 through the generation of type-specific neutralizing antibodies raised against the constituent virus-like particles (VLP) based upon the major capsid proteins (L1) of these genotypes. The vaccines a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bissett, Sara L., Mattiuzzo, Giada, Draper, Eve, Godi, Anna, Wilkinson, Dianna E., Minor, Philip, Page, Mark, Beddows, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228199/
https://www.ncbi.nlm.nih.gov/pubmed/25203446
http://dx.doi.org/10.1016/j.vaccine.2014.07.116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228199/
https://www.ncbi.nlm.nih.gov/pubmed/25203446
http://dx.doi.org/10.1016/j.vaccine.2014.07.116

Ejemplares similares